| |
| |
|
| Insider
Information: |
Pops Richard F |
| Relationship: |
Director |
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
4 |
|
| Direct
Shares |
1,303,786 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$37,782,416 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
1,303,786 |
|
|
| Total
Value |
$37,782,416 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Neurocrine Biosciences Inc |
NBIX |
Director |
2024-05-17 |
31,611 |
2005-11-23 |
0 |
Premium* |
|
|
Alkermes Plc |
ALKS |
Director and CEO, Alke... |
2024-02-08 |
1,179,675 |
2011-09-16 |
0 |
Premium* |
|
|
Epizyme, Inc. |
EPZM |
Director |
2013-05-30 |
60,000 |
|
0 |
Premium* |
|
|
Acceleron Pharma Inc |
XLRN |
Director |
2019-01-25 |
32,500 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
259 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 6 of 11
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ALKS |
Alkermes Plc |
Director and CEO, Alkermes plc |
• • – |
2020-03-01 |
4 |
D |
$20.84 |
$161,927 |
D/D |
(7,770) |
759,094 |
0 |
- |
|
| ALKS |
Alkermes Plc |
Director and CEO, Alkermes plc |
• • – |
2021-02-16 |
4 |
D |
$19.79 |
$159,784 |
D/D |
(8,074) |
769,145 |
0 |
- |
|
| ALKS |
Alkermes Plc |
Director and CEO, Alkermes plc |
• • – |
2021-02-17 |
4 |
D |
$19.97 |
$77,264 |
D/D |
(3,869) |
774,026 |
0 |
- |
|
| ALKS |
Alkermes Plc |
Director and CEO, Alkermes plc |
• • – |
2021-02-21 |
4 |
D |
$19.58 |
$281,678 |
D/D |
(14,386) |
792,040 |
0 |
- |
|
| ALKS |
Alkermes Plc |
Director and CEO, Alkermes plc |
• • – |
2021-09-14 |
4 |
D |
$30.60 |
$1,109,770 |
D/D |
(36,267) |
837,455 |
0 |
- |
|
| ALKS |
Alkermes Plc |
Director and CEO, Alkermes plc |
• • – |
2022-02-16 |
4 |
D |
$26.79 |
$215,338 |
D/D |
(8,038) |
847,542 |
0 |
- |
|
| ALKS |
Alkermes Plc |
Director and CEO, Alkermes plc |
• • – |
2022-02-21 |
4 |
D |
$25.08 |
$360,801 |
D/D |
(14,386) |
865,556 |
0 |
- |
|
| ALKS |
Alkermes Plc |
Director and CEO, Alkermes plc |
• • – |
2023-02-20 |
4 |
D |
$28.07 |
$1,491,780 |
D/D |
(53,145) |
1,034,867 |
0 |
- |
|
| ALKS |
Alkermes Plc |
Director and CEO, Alkermes plc |
• • – |
2023-02-21 |
4 |
D |
$27.77 |
$399,499 |
D/D |
(14,386) |
1,052,881 |
0 |
- |
|
| ALKS |
Alkermes Plc |
Director and CEO, Alkermes plc |
• • – |
2024-02-08 |
4 |
D |
$26.77 |
$2,456,335 |
D/D |
(91,757) |
1,179,675 |
0 |
- |
|
| EPZM |
Epizyme, Inc. |
Director |
– • – |
2013-05-30 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
60,000 |
|
- |
|
| XLRN |
Acceleron Pharma Inc |
Director |
– • – |
2013-09-18 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
28,750 |
|
- |
|
| NBIX |
Neurocrine Biosciences In... |
Director |
– • – |
2005-11-23 |
4 |
OE |
$5.25 |
$130,000 |
D/D |
20,000 |
20,000 |
|
- |
|
| ALKS |
Alkermes Plc |
Director and CEO, Alkermes plc |
• • – |
2012-02-01 |
4 |
OE |
$4.77 |
$376,850 |
D/D |
60,000 |
361,650 |
0 |
- |
|
| ALKS |
Alkermes Plc |
Director and CEO, Alkermes plc |
• • – |
2012-05-17 |
4 |
OE |
$0.00 |
$0 |
D/D |
8,125 |
348,807 |
0 |
- |
|
| ALKS |
Alkermes Plc |
Director and CEO, Alkermes plc |
• • – |
2012-07-03 |
4 |
OE |
$4.77 |
$144,526 |
D/D |
30,299 |
378,472 |
0 |
- |
|
| ALKS |
Alkermes Plc |
Director and CEO, Alkermes plc |
• • – |
2012-07-05 |
4 |
OE |
$4.77 |
$37,683 |
D/D |
7,900 |
356,073 |
0 |
- |
|
| ALKS |
Alkermes Plc |
Director and CEO, Alkermes plc |
• • – |
2012-07-09 |
4 |
OE |
$4.77 |
$294,791 |
D/D |
61,801 |
409,974 |
0 |
- |
|
| ALKS |
Alkermes Plc |
Director and CEO, Alkermes plc |
• • – |
2012-09-24 |
4 |
OE |
$7.36 |
$736,000 |
D/D |
100,000 |
448,173 |
0 |
- |
|
| ALKS |
Alkermes Plc |
Director and CEO, Alkermes plc |
• • – |
2012-10-01 |
4 |
OE |
$7.36 |
$736,000 |
D/D |
100,000 |
448,173 |
0 |
- |
|
| ALKS |
Alkermes Plc |
Director and CEO, Alkermes plc |
• • – |
2012-10-08 |
4 |
OE |
$7.36 |
$427,616 |
D/D |
58,100 |
406,273 |
0 |
- |
|
| ALKS |
Alkermes Plc |
Director and CEO, Alkermes plc |
• • – |
2012-10-09 |
4 |
OE |
$7.36 |
$308,384 |
D/D |
41,900 |
390,073 |
0 |
- |
|
| ALKS |
Alkermes Plc |
Director and CEO, Alkermes plc |
• • – |
2012-10-17 |
4 |
OE |
$7.36 |
$21,344 |
D/D |
2,900 |
351,073 |
0 |
- |
|
| ALKS |
Alkermes Plc |
Director and CEO, Alkermes plc |
• • – |
2012-11-12 |
4 |
OE |
$7.36 |
$89,056 |
D/D |
12,100 |
360,273 |
0 |
- |
|
| ALKS |
Alkermes Plc |
Director and CEO, Alkermes plc |
• • – |
2012-11-18 |
4 |
OE |
$0.00 |
$0 |
D/D |
125,000 |
473,173 |
0 |
- |
|
259 Records found
|
|
Page 6 of 11 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
